Showing results (81-90 of 99) with videos related to
Sort By:
Pageof 10
The Prostate|September 4, 2008
Dexamethasone did not suppress immune boosting by personalized peptide vaccination for advanced prostate cancer patientsMasayasu Naito, Kyogo Itoh, Nobukazu Komatsu, et al.Cancer Immunology, Immunotherapy : CII|February 10, 2015
Phase I trial of a cancer vaccine consisting of 20 mixed peptides in patients with castration-resistant prostate cancer: dose-related immune boosting and suppressionMasanori Noguchi, Gaku Arai, Kazumasa Matsumoto, et al.International Journal of Oncology|February 7, 2012
Personalized peptide vaccination in patients with refractory non-small cell lung cancerKoichi Yoshiyama, Yasuhiro Terazaki, Satoko Matsueda, et al.Oncology Reports|July 29, 2010
A phase II study of personalized peptide vaccination combined with gemcitabine for non-resectable pancreatic cancer patientsHiroaki Yanagimoto, Hisanori Shiomi, Sohei Satoi, et al.Cancer Immunology, Immunotherapy : CII|February 11, 2010
A randomized phase II trial of personalized peptide vaccine plus low dose estramustine phosphate (EMP) versus standard dose EMP in patients with castration resistant prostate cancerMasanori Noguchi, Tatsuyuki Kakuma, Hirotsugu Uemura, et al.Journal of Immunology Research|November 6, 2015
Phase II Study of Personalized Peptide Vaccination with Both a Hepatitis C Virus-Derived Peptide and Peptides from Tumor-Associated Antigens for the Treatment of HCV-Positive Advanced Hepatocellular Carcinoma PatientsShigeru Yutani, Kazuomi Ueshima, Kazumichi Abe, et al.Cancer Immunology, Immunotherapy : CII|October 3, 2015
Haptoglobin promoter polymorphism rs5472 as a prognostic biomarker for peptide vaccine efficacy in castration-resistant prostate cancer patientsHiromitsu Araki, Xiaoliang Pang, Nobukazu Komatsu, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|July 5, 2003
Peptide vaccination for patients with melanoma and other types of cancer based on pre-existing peptide-specific ctotoxic T-lymphocyte precursors in the peripheryShoko Tanaka, Mamoru Harada, Takashi Mine, et al.Cancer|November 11, 2011
Gene expression profiles in peripheral blood as a biomarker in cancer patients receiving peptide vaccinationNobukazu Komatsu, Satoko Matsueda, Kousuke Tashiro, et al.Clinical Lung Cancer|April 19, 2017
Feasibility Study of Personalized Peptide Vaccination for Advanced Small Cell Lung CancerShinjiro Sakamoto, Teppei Yamada, Yasuhiro Terazaki, et al.Pageof 10